基本信息
浏览量:66
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
In 1995 I retired from the University Of Texas Health Science Center. I have been very active as Scientific Director of the Path Medical Foundation. Currently, I am co-founder and Chairman, CEO & CSO of IGENE, LLC and Chairman & CSO GENUS Health LLC. My concept of Reward Deficiency Syndrome (RDS) is being embraced by world leaders in science and is part of the DSM –5, ASAM and SAGE Encyclopedia of Abnormal Psychology. The seminal DRD2 gene discovery has been confirmed in over 4,291 publications from laboratories all over the world. I serve as Editor-in-Chief Journal of Reward Deficiency Syndrome & Addictive Sciences and Co-EIC with Dr. Badgaiyan of the Journal Neuroimaging in Psychiatry & Neurology. Along with David E. Comings and Gerald Kozlowski and others we are credited with the development of the concept Reward Deficiency Syndrome and the Brain Reward Cascade. I am currently serving on fourteen other prestigious journal’s Editorial Boards. Currently I have been named Volunteer Full Professor of the Western University of Health Sciences Graduate School of Biomedical Sciences Pomona CA USA., Adjunct Research Professor, Human Integrated Services Unit University of Vermont Center for Clinical & Translational Science, College of Medicine, Burlington, VT.; Life Time Honorary Professor, Eötvös Loránd University, Institute of Psychology , Budapest , Hungary. I currently serve as Chief Scientific Advisor for Dominion Diagnostics, LLC North Kingstown Rhode Island. I have published over 500 abstracts, chapters and peer-reviewed articles, 15 books, numerous patents and received many awards for the seminal discovery along with Ernest P. Noble of the first confirmed association of the dopamine D2 receptor gene and addiction. I am in some circles considered the Father of “Psychiatric Genetics “and Amino-Acid Therapy for addiction.
I have been retired from a full –time position in Academia since 1995. However, over the cause of my long career, I received funding from NIAAA, NIDA, Foundations, State Government, Local Municipalities, and the Pharmaceutical Industry. I have been actively involved in obtaining US and Foreign Patents, for a number of commercial products. Over the many years of academic research, I have participated as PI or co-PI on a number of RO1 grants. The total grant funds over the years in Academia amounted to 2,798,035.
研究兴趣
论文共 415 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Gene & protein in diseaseno. 1 (2024)
FRONTIERS IN PUBLIC HEALTH (2024): 1274719-1274719
Current pharmaceutical biotechnologyno. 1 (2024): 42-57
Journal of personalized medicineno. 5 (2024): 500
Acta Scientific Neurologypp.12-18, (2024)
INNOSC theranostics & pharmacological sciencesno. 2 (2024): 1472-1472
CURRENT PHARMACEUTICAL BIOTECHNOLOGYno. 1 (2024): 42-57
Kai-Uwe Lewandrowski,Alireza Sharafshah,John Elfar, Sergio Luis Schmidt,Kenneth Blum, Franklin Todd Wetzel
Cellular and molecular neurobiologyno. 1 (2024): 47-47
JOURNAL OF PEDIATRIC ORTHOPAEDICS-PART Bno. 4 (2024): 399-406
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn